d-0502
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 18, 2018 (NCT03471663)
Timeline
Indications
Mechanism of action
- Estrogen receptorINHIBITOR
Estrogen receptor inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06954961 | Phase 3 | Sep 15, 2022 | InventisBio Inc. |
| NCT05339633 | Phase 1 | Mar 29, 2022 | InventisBio Inc. |
| NCT05226338 | Phase 1 | Oct 27, 2021 | InventisBio Inc. |
| NCT03810625 | Phase 1 | Oct 18, 2018 | InventisBio Inc. |
| NCT03471663 | Phase 1 | Mar 18, 2018 | InventisBio Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| InventisBio Inc. | For profit | 5 | 5 | 2 | 2018 |
1 organizations
Page 1 / 1